Zacks Investment Research on MSN

Oracle (ORCL) Down 12.1% Since Last Earnings Report: Can It Rebound?

A month has gone by since the last earnings report for Oracle (ORCL). Shares have lost about 12.1% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up ...

Here's How Much You Would Have Made Owning Oracle Stock In The Last 15 Years

Oracle (NYSE: ORCL) has outperformed the market over the past 15 years by 4.75% on an annualized basis producing an average annual return of 17.03%. Currently, Oracle has a market capitalization of ...

BioXcel Therapeutics Announces Positive Results from Correlation Study Supporting SERENITY At-Home Exploratory Efficacy Outcomes

Completes clinical trials required by FDA for sNDA submission planned for the first quarter of 2026NEW HAVEN, Conn., Oct. 14, ...

If AI Is A Bubble, The Signs Were Staring Us In The Face

Inflation risks are rising due to tariffs and retailer price hikes. AI infrastructure spending is surging, echoing the Dot ...
Newseria BIZNES

Decentralized Clinical Trials Market Projected to Reach $16.68 Billion with 17.5% CAGR by 2029

LONDON, GREATER LONDON, UNITED KINGDOM, October 10, 2025 /EINPresswire.com/ -- What Is The Expected Cagr For The Decentralized Clinical Trials Market Through 2025? There has been a quick expansion in ...